172 related articles for article (PubMed ID: 24756092)
21. Genetic polymorphisms in the DNA repair gene, XRCC1 associate with non-Hodgkin lymphoma susceptibility: A systematic review and meta-analysis.
Li Y; Bai O; Cui J; Li W
Eur J Med Genet; 2016 Feb; 59(2):91-103. PubMed ID: 26723520
[TBL] [Abstract][Full Text] [Related]
22. Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma.
Chen Y; Zheng T; Lan Q; Foss F; Kim C; Chen X; Dai M; Li Y; Holford T; Leaderer B; Boyle P; Chanock SJ; Rothman N; Zhang Y
Blood; 2011 Jan; 117(2):585-90. PubMed ID: 20952689
[TBL] [Abstract][Full Text] [Related]
23. Single nucleotide polymorphisms of DNA base-excision repair genes (APE1, OGG1 and XRCC1) associated with breast cancer risk in a Chinese population.
Luo H; Li Z; Qing Y; Zhang SH; Peng Y; Li Q; Wang D
Asian Pac J Cancer Prev; 2014; 15(3):1133-40. PubMed ID: 24606430
[TBL] [Abstract][Full Text] [Related]
24. Association of VEGF genetic polymorphisms with the clinical characteristics of non-Hodgkin's lymphoma.
Diao LP; Yu XM; Gao YH; Li Y; Liu HS; Liu LH; Zhou RM; Wang N; Wu LL; Wang SJ
J Cancer Res Clin Oncol; 2009 Nov; 135(11):1473-81. PubMed ID: 19649652
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.
Diao LP; Ma H; Wei GC; Li T; Liu HS; Liu LH; Wu LL; Zhao GM; Gao YH
Int J Cancer; 2012 Sep; 131(5):1095-103. PubMed ID: 22020421
[TBL] [Abstract][Full Text] [Related]
26. PARP-1 Val762Ala polymorphism is associated with reduced risk of non-Hodgkin lymphoma in Korean males.
Jin XM; Kim HN; Lee IK; Park KS; Kim HJ; Choi JS; Juhng SW; Choi C
BMC Med Genet; 2010 Mar; 11():38. PubMed ID: 20196871
[TBL] [Abstract][Full Text] [Related]
27. H2AFX polymorphisms are associated with decreased risk of diffuse large B cell lymphoma in Koreans.
Jin XM; Kim HN; Shin MH; Lee IK; Lee JS; Lee JH; Kim HJ; Choi JS; Juhng SW; Choi C
DNA Cell Biol; 2011 Dec; 30(12):1039-44. PubMed ID: 21631283
[TBL] [Abstract][Full Text] [Related]
28. DNA repair gene polymorphisms in B cell non-Hodgkin's lymphoma.
Bahceci A; Paydas S; Tanriverdi K; Ergin M; Seydaoglu G; Ucar G
Tumour Biol; 2015 Mar; 36(3):2155-61. PubMed ID: 25400036
[TBL] [Abstract][Full Text] [Related]
29. One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia.
Lee KM; Lan Q; Kricker A; Purdue MP; Grulich AE; Vajdic CM; Turner J; Whitby D; Kang D; Chanock S; Rothman N; Armstrong BK
Hum Genet; 2007 Dec; 122(5):525-33. PubMed ID: 17891500
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study.
Purdue MP; Lan Q; Kricker A; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
Carcinogenesis; 2007 Mar; 28(3):704-12. PubMed ID: 17056605
[TBL] [Abstract][Full Text] [Related]
31. MDR1 gene polymorphisms and acute myeloid leukemia AML susceptibility in A Moroccan adult population: A case-control study and meta-analysis.
Kaltoum ABO; Sellama N; Hind D; Yaya K; Mouna L; Asma Q
Curr Res Transl Med; 2020 Jan; 68(1):29-35. PubMed ID: 31307954
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma.
Lan Q; Zheng T; Shen M; Zhang Y; Wang SS; Zahm SH; Holford TR; Leaderer B; Boyle P; Chanock S
Hum Genet; 2007 Apr; 121(2):161-8. PubMed ID: 17149600
[TBL] [Abstract][Full Text] [Related]
33. Role of one-carbon metabolizing pathway genes and gene-nutrient interaction in the risk of non-Hodgkin lymphoma.
Li Q; Lan Q; Zhang Y; Bassig BA; Holford TR; Leaderer B; Boyle P; Zhu Y; Qin Q; Chanock S; Rothman N; Zheng T
Cancer Causes Control; 2013 Oct; 24(10):1875-84. PubMed ID: 23913011
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor receptor 4 polymorphisms and the prognosis of non-Hodgkin lymphoma.
Cha Z; Zang Y; Guo H; Gu H; Tu X; Song H; Qian B
Mol Biol Rep; 2014 Feb; 41(2):1165-70. PubMed ID: 24381107
[TBL] [Abstract][Full Text] [Related]
35. Role of polymorphisms in BCL-2 and BAX genes in modulating the risk of developing non-Hodgkin lymphoma.
Wang WL; Tao YP; Han XL; Li X; Zi YM; Yang C; Li JD
Leuk Lymphoma; 2014 Jul; 55(7):1602-8. PubMed ID: 24024471
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms in methylenetetrahydrofolate reductase gene and risk of non-Hodgkin lymphoma in a multi-ethnic population.
Suthandiram S; Gan GG; Zain SM; Haerian BS; Bee PC; Lian LH; Chang KM; Ong TC; Mohamed Z
J Hum Genet; 2014 May; 59(5):280-7. PubMed ID: 24646728
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in the nucleotide excision repair gene ERCC2/XPD and risk of non-Hodgkin lymphoma.
Worrillow L; Roman E; Adamson PJ; Kane E; Allan JM; Lightfoot TJ
Cancer Epidemiol; 2009 Oct; 33(3-4):257-60. PubMed ID: 19736055
[TBL] [Abstract][Full Text] [Related]
38. Influence of Genotype and Haplotype of MDR1 (C3435T, G2677A/T, C1236T) on the Incidence of Breast Cancer--a Case-Control Study in Jordan.
Abuhaliema AM; Yousef AM; Elmadany NN; Bulatova NR; Awwad NM; Yousef MA; Al Majdalawi KZ
Asian Pac J Cancer Prev; 2016; 17(1):261-6. PubMed ID: 26838221
[TBL] [Abstract][Full Text] [Related]
39. The association of polymorphisms in DNA base excision repair genes XRCC1, OGG1 and MUTYH with the risk of childhood acute lymphoblastic leukemia.
Stanczyk M; Sliwinski T; Cuchra M; Zubowska M; Bielecka-Kowalska A; Kowalski M; Szemraj J; Mlynarski W; Majsterek I
Mol Biol Rep; 2011 Jan; 38(1):445-51. PubMed ID: 20364408
[TBL] [Abstract][Full Text] [Related]
40. [Relation between single Nucleotide Polymorphisms of CYP3A5 Gene and MDR1 Gene Loci and Risk of CML Cytogenetic Relapse].
Yang ZY; Zhang YS; Liang CX; Zhou ZJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec; 26(6):1644-1648. PubMed ID: 30501698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
